Navigation Links
Carmel Pharma Introduces PhaSeal Secondary Set (C60)
Date:11/1/2009

New Component Streamlines Safe Spiking, Priming and IV Bag Infusion with Hazardous Drugs

Columbus, OH (Vocus) October 31, 2009 -- Carmel Pharma, maker of the PhaSeal System for the safe handling of hazardous drugs, now offers the Secondary Set (C60) for safe, streamlined preparation and administration of IV bag infusions.

For safety and ease of use, the non-vented Secondary Set offers the following features:

 
  • Drip chamber (20 drops/mL)
  • Flow stop to facilitate priming of the Secondary Set from the bag prior to adding the drug
  • Universal spike with built-in PhaSeal Connector for safe, leakproof transfer of the drug to the IV bag
  • DEHP-free PVC tubing (40 in.)

For more information or to order, call 866-487-9250 or visit www.PhaSeal.com.

PhaSeal is more than a system for the safe handling of hazardous drugs. It's the only clinically proven closed-system drug transfer device (CSTD) available today and is validated by more than 10 independent, peer-reviewed, published clinical studies. Distinguished by prominent thought leaders as the "Gold Standard" in safe handling, PhaSeal's airtight Expansion Chamber and leakproof Double Membrane connections prevent exposure to hazardous drugs, including aerosols and vapors, and make it the only system that meets the National Institute for Occupational Safety and Health (NIOSH) and International Society of Oncology Pharmacy Practitioners (ISOPP) definition of a true CSTD. Its
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Carmel Pharma Introduces PhaSeal Secondary Set (C60)
2. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
3. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
4. China Pharma Holdings, Inc. to Report Third Quarter 2009 Financial Results on November 12, 2009
5. Cardinal Health Foundation, The Ohio State University College of Pharmacy Join Forces to Prevent Prescription Medication Abuse
6. WuXi PharmaTech Schedules Third-Quarter 2009 Earnings Release
7. 5 Steps to Pharmaceutical Marketing Happiness
8. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
9. Vestara Awarded MedAssets Supplier Contract For Automated Pharmaceutical Waste Management Solution
10. CVS/pharmacy Rewards Shoppers For Passing on Plastic Bags
11. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Carmel Pharma Introduces PhaSeal Secondary Set (C60) 
(Date:8/31/2015)... ... August 31, 2015 , ... ... may be at a greater risk for injury, potentially because they are more ... of Pittsburgh Graduate School of Public Health analysis discovered. , The research, ...
(Date:8/31/2015)... York, NY (PRWEB) , ... August 31, 2015 ... ... simulations that enable users to develop skills and assess their competencies in managing ... of research, will present at the Defense Centers of Excellence for Psychological ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... On ... With A Mission” at the Adams County Fairgrounds in Mendon, IL. The purpose behind ... school districts of Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music ...
(Date:8/31/2015)... ... August 31, 2015 , ... The German soccer league (DFL ... (CMS) and make website updates quicker and more flexible. The company's CMS solution ... Bundesliga (the German equivalent of the U.S. Soccer Federation) more modern, exciting and ...
(Date:8/31/2015)... ... ... “My mother and husband use oxygen therapy and the tubing irritates the ... be a comfortable way to prevent the irritation, so I invented this.” She invented ... secure way to anchor the cannula tubing used in oxygen therapy and it prevents ...
Breaking Medicine News(10 mins):Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:On the Ball with FirstSpirit: German Soccer League (DFL Digital Sports) Opts for e-Spirit’s CMS 2Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2
... Recent research has revealed that women aged 60 and ... heart attack compared to others. The results of the ... such patients when compared to heart attack patients who ... been published in the April 24 issue of the ...
... Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, ... Shipments of pravastatin sodium tablets// have been started ... mg strengths. ,Watson Pharmaceuticals, Inc. has ... leading specialty pharmaceutical company that specializes in the ...
... Pyszczynski, professor, Psychology, University of Colorado at Colorado ... Zarand, //Iran, Sheldon Solomon, professor, Psychology, Skidmore College, ... University of Arizona, Tuscon. , In ... were questioned and were found that thoughts of ...
... practice followed is to begin immunizations of babies at two ... not achieve// the desired purpose, due to the incapacity of ... the vaccines. Now, according to a new study conducted by ... response in newborns, with a certain type of molecule present ...
... Health Organization (WHO) is in the process of updating the ... the new one, which will present// the rates at which ... form. ,The 20-year old charts are said to ... revision is based on growth data from breast-fed babies who ...
... of two decades ago still holds more than a third ... here still continues// to cause cancer in children according to ... ,According to official measurements published in the report at least ... for centuries as a result of the disaster. ...
Cached Medicine News:Health News:Depression Accompanies Heart Attacks in Younger Women 2
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Regulatory ... and government, where regulations are often strict and ... is driving a demand for professionals who have ... these regulations across a product lifecycle and demonstrate ... The University of California, Irvine Extension , ...
(Date:8/31/2015)... , August 31, 2015 ... (TASE: BOLT, OTCQX: BLGTY) ("BioLight" or the "Company"), ... biomedical innovations in ophthalmology and cancer diagnostics, today ... (TASE: MCTC), has identified several new genetic markers ... jawbone in patients treated with bisphosphonate drugs and ...
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4
... Plus, Higher then Expected MCI Prevalence Shows Urgent ... Two studies related to,experimental Alzheimer,s therapies reported ... Conference on Alzheimer,s,Disease (ICAD 2008) in Chicago., ... AL-108, targeted early,abnormal brain changes in a protein ...
... July 28 Cardium Therapeutics,(Amex: CXM ) ... as Chief,Medical Officer to lead the Company,s late-stage ... the MATRIX Phase 2b,clinical study that is evaluating ... ulcers, and the AWARE Phase 3 clinical study ...
Cached Medicine Technology:Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 2Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 3Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 4Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 5Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 6Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 2Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 3Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 4Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 5
... intravascular catheters provide a simple, efficient ... pressures in the heart or cardiovascular ... are ideal for high fidelity pressure ... from 2 to 7 French and ...
... These dual pressure sensor ... sampling/slow-speed injection, slow-speed injection/guide wire, ... model SPC-784A for high-speed injection ... side openings and an open-end ...
... These dual pressure sensor catheters ... injection, slow-speed injection/guide wire, or ... SPC-784A for high-speed injection has ... openings and an open-end pigtail ...
... Dual Pressure Sensor Intravascular Mikro-Tip ... a line of dual pressure sensor ... measurements. These catheters are suitable for ... between chambers, or across a vascular ...
Medicine Products: